it is a good result in isolation mate i agree.
but in true RXL style need review in context of other information provided.
The section below suggests other hits around it are weak from an UG point of view
reading the tables in the report - there is no assay column, but an intersection table. Thats ok, but it's suggesting there is a lot of weighting in one, maybe a few assays.
reading the JORC table, assays are uncut -this is also OK, but for a 30m intersection you'd want to be be comfortable this isnt just one nugget in the core sample interval bulking out the reportable intercept.
For this to be real and relevant, it needs to be repeatable. More transparency required, this project still lacks credibility in the market IMO.
it is a good result in isolation mate i agree.but in true RXL...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $216.1M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 28.5¢ | $282.5K | 965.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101762 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 117116 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RXL (ASX) Chart |